TP53 and lymphoma: Indeed, p‐ERK expression levels were significantly increased in Ripk3−/−p53−/−thymic lymphomas compared to Ripk3+/+p53−/‐ thymic lymphomas (Figure 4G) suggesting a critical role of RIPK3 in suppressing ERK activation.